HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/28/2012 -- Life Partners Hol (NasdaqNM:LPHI) is -0.70 - -19.13% from the previous close of $3.66. It traded between $2.93 - 4.09 with total traded volume of 4694211 shares. Keep a close eye on LPHI, as the stock has been showing unusual moves over the past weeks. At Current market price, LPHI has recovered +174.07% from its 52-week Low of 1.08 and has Pulled back -60.48% from its 52-week high of 7.49. Life Partners Holdings, Inc.(NASDAQ:LPHI) shares declined 7.38% to $3.41 in the morning hour after the company announced that Travis County District Judge Stephen Yelenosky ruled that the life settlement transactions that it facilitates are not securities under Texas law. Although subject to appeal, the ruling effectively ends the Texas Attorney General’s suit against Life Partners, which had asserted that the 21-year-old company’s life settlement transactions were securities under Texas law.
Get a free trend analysis on LPHI Click Here
Cytori Therapeuti (NGM:CYTX) reported EPS of -0.575. For the Current Fiscal year, the company is expected to report EPS of -0.59. For the Next Quarter and Next Year, the company is expected to report EPS of -0.15 and -0.47 respectively. At Current Market Price, CYTX is in distance of +12.37% from its 50-day Moving Average price of $3.4351 and +42.60% from its 200-day Moving Average price of $2.7069. Cytori Therapeutics Inc. (USA)(NASDAQ:CYTX) shares dropped 10.53% and closed at $4.25 in the last trading session. The company, on Sept. 13, announced that a 40-patient, multi-center investigator-sponsored and funded clinical study in Japan using the Celution(R) System has been approved under the Ministry of Health, Labor and Welfare (MHLW) Guidelines on Clinical Research Using Human Stem Cells.
Get a free trend analysis on CYTX Click Here
StemCells, Inc. (NCM:STEM) is very active today and traded between $1.93 - 2.27 with total traded volume of 10895117 shares. At a current price of 2.12, STEM is +0.19 - +9.84% from the previous close of $1.93. Moreover, At Current Market Price, STEM is in distance of +13.58% from its 50-day Moving Average price of $1.8666 and +72.70% from its 200-day Moving Average price of $1.2276. StemCells, Inc.(NASDAQ:STEM) shares increased 7.25% to $2.07 after the company announced that the first patient with an incomplete spinal cord injury has been enrolled in the Company's Phase I/II clinical trial in chronic spinal cord injury and transplanted with the Company's proprietary HuCNS-SC(R) neural stem cells. The patient, a Canadian man who suffered a thoracic spinal cord injury from a sports-related accident, was administered the cells yesterday at Balgrist University Hospital, University of Zurich, a world leading medical center for spinal cord injury and rehabilitation.
Get a free trend analysis on STEM Click Here
OCZ Technology Gr (NCM:OCZ) is +0.08 - +2.40% from the previous close of $3.33. It traded between $3.23 - 3.79 with total traded volume of 6916179 shares. Keep a close eye on OCZ, as the stock has been showing unusual moves over the past weeks. At Current market price, OCZ has recovered +12.54% from its 52-week Low of 3.03 and has Pulled back -66.07% from its 52-week high of 10.05. OCZ Technology Group Inc (NASDAQ:OCZ) moved up 6.91% to $ 3.56 on a traded volume of 12k shares. Recently, the Chief Executive Officer, Ryan Petersen has resigned from his position. The Board of Directors has appointed Alex Mei, Executive Vice President and Chief Marketing Officer as Interim Chief Executive Officer, effective immediately. Mr. Mei’s appointment follows the Board’s acceptance of Ryan Petersen’s resignation. Mr. Mei will also maintain his current responsibilities as EVP and Chief Marketing Officer until a permanent CEO has been selected.
Get a free trend analysis on OCZ Click Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)